Faster radiation scheduling for aggressive non-small cell lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial studies a new way of giving radiation therapy to the chest for lung cancer that is growing quickly. The approach uses a special schedule to damage the cancer more effectively, which might improve how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- Your lung cancer is the non-small cell type and is growing quickly.
- Your doctors have decided that you should get radiation therapy to the chest, either to try to cure the cancer or to relieve symptoms.
- You have not had a heart attack or severe heart problems in the last 6 months.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.
- You are not in any other experimental treatment study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests whether adding a high, focused dose of radiation to the usual first treatment (chemo and/or immunotherapy) can help people with non-small cell lung cancer that has spread to a limited number of spots (up to 5). The goal is to see if this approach improves how well the treatment works.
This trial tests combining immunotherapy with a shorter course of chemoradiation for locally advanced non-small cell lung cancer that hasn't spread. It aims to see if this approach is more effective and tolerable than standard treatment.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
This trial studies a different way to deliver radiation to people with locally advanced, non-operable non-small cell lung cancer. It may help by aiming to treat the tumor effectively with a different radiation timing and dose pattern.
This trial tests a personalized, faster course of radiation combined with chemotherapy for lung cancer. It aims to improve treatment effectiveness while reducing side effects by tailoring the radiation plan to each patient.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.